Compare · head to head
Adaptive Biotechnologies vs Zenas Biopharma
Zenas Biopharma ranks higher overall — 360 rank 42 vs 20.
Zenas Biopharma leads on Growth (54 vs 48) and Sentiment (60 vs 48). The two are close on Quality and Safety.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Life Sciences Tools & Services | Biotechnology |
| Size | Medium | Small |
| ISIN | US00650F1093 | US98937L1052 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 20 | 42 |
| Value | 38 | NR |
| Quality | 42 | 38 |
| Growth | 48 | 54 |
| Safety | 41 | 39 |
| Sentiment | 48 | 60 |
| Quality details | ||
| Profitability | 31 | 26 |
| Cash Truth | 53 | NR |
Adaptive Biotechnologies vs Caribou BiosciencesAdaptive Biotechnologies vs GeronAdaptive Biotechnologies vs PersonalisAdaptive Biotechnologies vs Legend BiotechAdd a third stock →
Full analyses: Adaptive Biotechnologies · Zenas Biopharma
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100